- recruitingPHASE3
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
This study is for people who have already taken part in a trial for the medicine Benralizumab (Fasenra) for asthma, EGPA, or HES. If the medicine helped them, this study offers a way to continue receiving it while doctors monitor their health and the medicine's long-term effects.
United States · Argentina · Austria - recruitingPHASE3
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
This study is looking into a medicine called benralizumab for children aged 6 to 17 with rare blood conditions called EGPA or HES. We want to see if it's safe, how well it works, and how the body handles it over time.
United States · Brazil · Canada